Search results
Results From The WOW.Com Content Network
The first modern epinephrine autoinjector, the EpiPen, was invented in the mid-1970s at Survival Technology in Bethesda, Maryland, US by Sheldon Kaplan [11] [12] and was first approved for marketing by the FDA in 1987. [13] One of the people who helped in making the EpiPen was Richard B. Toren.
One study of over 85,000 people with ADHD found that girls get diagnosed and treated for ADHD about ... than boys (55.8% vs. 69.7%, respectively). ... The underdiagnosis of ADHD in women and girls ...
This is a list of investigational attention deficit hyperactivity disorder drugs, or drugs that are currently under development for clinical use in the treatment of attention deficit hyperactivity disorder (ADHD) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in ...
Hyperactivity has long been part of the human condition, although hyperactive behaviour has not always been seen as problematic. [1] [page needed]The terminology used to describe the symptoms of attention deficit hyperactivity disorder, or ADHD, has gone through many changes over history, including "minimal brain damage", "minimal brain dysfunction", "learning/behavioral disabilities" and ...
The FDA just approved Neffy, a needle-free EpiPen alternative. Here's when it's hitting shelves—and allergists tell 'Women's Health' if they recommend it.
As the CDC reveals a surge in Americans with ADHD, many are reporting difficulty in accessing care, including long waits for evaluations, missed diagnoses, and struggles to find medications that ...
A survey conducted by the Centers for Disease Control and Prevention in 2011–2012 found 11% of children between the ages of 4 and 17 were reported to have ever received a health care provider diagnosis of ADHD at some point (15% of boys and 7% of girls), [183] a 16% increase since 2007 and a 41% increase over the last decade. [184]
Between 2001 and 2022, suicide rates actually increased significantly for men and women over 55, while it declined for those age 15 to 34. Making sense of the statistics